Research amongst major European companies shows that they are increasingly concerned about the competition they face for deals from private equity funds. Companies see them becoming more aggressive, more determined, more streetwise and are concerned about their impact on deal valuations.
US conglomerate J.M. Huber has agreed to buy the Italian specialty fertilizers producer
Deal is first full exit from specialist healthcare investor's maiden mid-market fund
Buy-and-build specialist looks for portfolio add-ons as it contemplates hitting the road for a new fund in 2023
Three existing partners will lead the California office, which is the GP’s first beyond Europe